According to MarketsandMarketstm, the Next-Generation Sequencing Market is projected to grow from about USD 14.94 billion in ...

Advancements in AI, multi-omics, and genome editing are transforming life sciences and biotechnology, addressing new ...

Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

Peer-reviewed discovery platform and data in PNAS show that single transcription factor modulation reverses aging-associated gene expression and restores healthy cellular and tissue function in models ...

ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.

Explore how stressors during pregnancy influence foetal brain development and the impact on future neurodevelopmental ...

Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud-based research software platform designed to analyse and visualise ...

Illumina is building the most comprehensive multiomic solutions in the industry, anchored on its world-class sequencing platforms for unmatched quality and scale. For research and pharma innovators, ...